latest news releases from the newsroom
BSD Medical Corporation
University of Dusseldorf Treats First Patient With New BSD-2000/3D/MR Hyperthermia System by BSD Medical Corporation
SALT LAKE CITY, Dec. 23, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the first patient, a 13-year-old boy, has been treated using a BSD 2000/3D/MR Hyperthermia System at the Heinrich Heine University of Dusseldorf. The new system utilizes sophisticated treatment applicators that were specifically designed for pediatric treatments. The new system was designed to deliver hyperthermia therapy while simultaneously monitoring the treatment using magnetic resonance imaging (MRI). The purchase of the system was made possible by a multi-million Euro donation from the Parents' Initiative Pediatric Cancer Clinic.